McKesson Corporation: 10-K Risk Factor Changes

2026 vs 2025  ·  SEC EDGAR  ·  2026-05-22
Other years: 2025 vs 2024 · 2024 vs 2023
⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

McKesson's 2026 10-K reflects a strategic pivot toward emerging operational risks, adding three new disclosures centered on artificial intelligence integration and the planned Medical-Surgical Solutions separation while removing four risks related to controlled substance distribution costs. The company substantively modified 11 risk factors, with notable revisions to technology performance, anti-corruption compliance, acquisition integration, and information systems risks, suggesting heightened focus on execution risks tied to its corporate restructuring and digital transformation initiatives.

✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

3
New Risks
4
Removed
11
Modified
27
Unchanged
🟢 New in Current Filing

The adoption and use of AI in our business operations exposes us to risks and uncertainties.

We increasingly rely on technologies powered by or incorporating AI in our internal operations and business processes. The use of AI technologies introduces risks and uncertainties. AI can generate outputs that are false, misleading, incomplete, biased, or inconsistent. AI…

Read full text

We increasingly rely on technologies powered by or incorporating AI in our internal operations and business processes. The use of AI technologies introduces risks and uncertainties. AI can generate outputs that are false, misleading, incomplete, biased, or inconsistent. AI performance may degrade over time, or earlier than we planned, due to changes in inputs, data drift, updates by vendors, adversarial manipulations, and other causes. Our investments in AI may not yield anticipated benefits, and we might expend significant resources to maintain responsible and effective AI capabilities. Reliance on third-party AI tools and solutions may expose us to risks that are outside of our control, including compliance gaps. Our AI policies and safeguards may not be sufficient to protect us against negative outcomes, such as the misuse or loss of data or the compromise of our intellectual property. Any of the foregoing risks could adversely impact our reputation, our business operations, and our financial position or results of operations.

🟢 New in Current Filing Our planned separation of Medical-Surgical Solutions is contingent upon the satisfaction of certain conditions, may not be completed on the currently contemplated terms or timeline, or at all, and, if completed, may not achieve the intended financial and strategic benefits. 🔒
🟢 New in Current Filing McKESSON CORPORATION 🔒
🔴 No Match in Current Filing We experience increased costs to distribute controlled substances such as opioids. 🔒
🔴 No Match in Current Filing McKESSON CORPORATION 🔒
🔴 No Match in Current Filing McKESSON CORPORATION 🔒
🔴 No Match in Current Filing McKESSON CORPORATION 🔒
🟡 Modified Our technology products or services might not conform to specifications or perform as we intend. 🔒
🟡 Modified Anti-bribery and anti-corruption laws increase our compliance burden and expose us to risks. 🔒
🟡 Modified We might be unable to successfully complete or integrate acquisitions or other strategic transactions, and our investments in businesses may not perform as we expect. 🔒
🟡 Modified We experience significant problems with information systems or networks. 🔒
🟡 Modified We may be unsuccessful in achieving our strategic growth objectives. 🔒
🟡 Modified We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models. 🔒
🟡 Modified From time to time we have difficulties in sourcing or selling products due to a variety of causes and are adversely impacted by disruptions or changes in product supply. 🔒
🟡 Modified INDEX TO RISK FACTORS 🔒
🟡 Modified Privacy, cybersecurity, data protection, and AI laws and guidance increase our compliance burden and expose us to risks. 🔒
🟡 Modified McKESSON CORPORATION 🔒
🟡 Modified We are subject to extensive, complex, challenging, and frequently changing healthcare, environmental, and other laws, and may experience increased costs to distribute controlled substances such as opioids. 🔒
17 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get full access — from $29/month Already a Pro subscriber? View full diff →